Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population-Reference-Cited by-同舟云学术

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population

Published:2021-03-18 Issue:8 Volume:10 Page:2690-2702
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Goyal Ravi K.¹^ORCID,Nagar Saurabh P.¹,Kabadi Shaum M.²,Le Hannah²,Davis Keith L.¹,Kaye James A.³

Affiliation:

1. RTI Health Solutions Research Triangle Park NC USA

2. AstraZeneca Gaithersburg MD USA

3. RTI Health Solutions Waltham MA USA

Funder

AstraZeneca

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3855

Reference31 articles.

1. American Cancer Society.Cancer Facts & Figures.2020. Available at:https://www.cancer.org/content/dam/cancer‐org/research/cancer‐facts‐and‐statistics/annual‐cancer‐facts‐and‐figures/2020/cancer‐facts‐and‐figures‐2020.pdf. Accessed: June 9 2020.

2. Chronic Lymphocytic Leukemia

3. National Comprehensive Cancer Network.Clinical practice guidelines in oncology (NCCN Guidelines®): chronic lymphocytic leukaemia/small lymphocytic lymphoma.2020. Available at:https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed: May 26 2020.

4. American Cancer Society.Cancer Facts & Figures:2018. Available at:https://www.cancer.org/research/cancer‐facts‐statistics/all‐cancer‐facts‐figures/cancer‐facts‐figures‐2018.html. Accessed: May 4 2020.

5. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor–Based Regimens in the Second-Line Setting;JCO Oncology Practice;2024-08

3. Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry;Leukemia Research;2024-05

4. Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia;Journal of Managed Care & Specialty Pharmacy;2024-05

5. A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022);eJHaem;2024-04